Orexo sues Sun Pharma over opioid dependence generic
16-09-2020
US states sue 26 drugmakers over alleged price fixing
11-06-2020
44 states accuse big pharma of price fixing generics market
13-05-2019
Pavel Kapysh / Shutterstock.com
A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Generics, Sun Pharma, Taro, Sandoz, price-fixing, antitrust, DoJ, prosecutors, charges, investigation
